In a Series B financing round, INSERM spin-off Acticor Biotech has raised €15.3m from European and Asian...
Up To Date
Latest News
Multinational biotherapeutics company HiFiBiO Therapeutics announced that it has taken over early stage...
Roche has announced that in a Phase III trial, its antibody-drug conjugate Kadcyla showed improved invasive...
Targovax ASA has reported promising disease-free survival (DFS) data from Tg01 in resected pancreatic cancer.
Six years after the European Commission created the world's first bioeconomy strategy and action plan, it...
T cells target a bacterial variant of a human enzyme promoting autoimmune diseases such as Multiple...